Ribovate Therapeutics Ribovate is developing the next generation targeted mRNA-lipid nanoparticle therapeutic platform. Startup Details Co-Founded by: Drew Weissman and Hamideh Parhiz Participates in PCI Ventures UPstart Recent News All PCI Ventures Posts PCI Hosts its 7th Annual Innovation@Penn Conference Penn Startups Raising Money in 2023 PCI Ventures @ Pennovation Works Showcase Shines Spotlight on Penn-Affiliated Startups Making a Difference Penn Spinout and I-Corps Participant Innervace Raises $40 Million for Parkinson’s Disease Research